Massachusetts residents requiring cancer screenings, diabetes medications and other essential medical treatments will soon experience shorter wait times for care following a regulatory overhaul aimed at curbing insurance company delays. Governor Maura Healey announced Thursday, Nov. 14, 2024, that state health officials are updating regulations to eliminate the advance approvals often required for common tests and treatments.
These requirements, known as prior authorizations, force physicians to obtain a formal sign-off from an insurance provider before a patient can receive specific care. Administration officials stated that the Massachusetts prior authorization changes will eliminate thousands of these authorizations annually, reducing the administrative burden on clinics and removing barriers for patients in critical windows of illness.
Speaking to healthcare workers and the media at the Dana-Farber Cancer Institute, Gov. Healey emphasized the human cost of bureaucratic delays. “When you’re sick, it is so important that you’re able to get that care as quickly as possible,” Healey said. “That you’re able to get in to see the doctor, to see the specialist, to get that screening, to get that blood work, to get that medication.”
As a physician, I have seen how these “sign-offs” function as a bottleneck in clinical practice. While insurers frame them as a tool for appropriateness, in practice, they often result in a “wait-and-see” period that can allow a manageable condition to escalate into an emergency.
Which services are no longer subject to prior authorization?
The new regulations target several high-impact areas of medicine where delays are most detrimental to patient outcomes. The prohibition on prior authorizations now extends to:
- Emergency and Urgent Care: Immediate interventions will no longer require advance insurance approval.
- Primary Care: Routine visits and basic diagnostic tools used by family physicians.
- Maternity Care: Essential prenatal and postnatal services to ensure safer pregnancy outcomes.
- Chronic Disease Management: Patients with specific chronic conditions will no longer need insurance approval for imaging tests, physical therapy and certain medications.
the regulations address the “approval loop” that often plagues patients with long-term illnesses. Patients with chronic diseases will no longer be required to undergo annual approvals to continue treatments they have already started, providing a more stable continuum of care.
Streamlining the approval process
For treatments that still require authorization, the state is imposing stricter timelines on insurers. Under the new rules, insurance companies must respond to urgent patient requests within 24 hours. This is a significant shift from previous industry standards, where “urgent” requests could still take several business days to process.
The following table outlines the primary shifts in how medical approvals will be handled in Massachusetts:
| Service Category | Previous Requirement | New Regulation |
|---|---|---|
| Primary & Maternity Care | Often required prior authorization | Prior authorization prohibited |
| Chronic Disease Imaging/PT | Case-by-case insurance approval | Approvals eliminated for certain conditions |
| Urgent Requests | Variable response times | Mandatory 24-hour response |
| Existing Chronic Treatment | Frequent annual renewals | Annual approvals eliminated |
The clinical impact: Why timing matters
The announcement took place at Dana-Farber because the stakes are highest in oncology. For cancer patients, the window between a suspicious finding and the start of treatment is a critical determinant of survival and quality of life.
Dr. Craig Bunnell, chief medical officer at Dana-Farber, noted that even a marginal delay can have cascading effects on a patient’s trajectory. “Every minute matters,” Bunnell said. “For our patients, a delay of even a couple days can affect treatment, outcomes and peace of mind.”
From a public health perspective, this move aligns with a growing national conversation about “administrative waste.” When a doctor spends hours on the phone with an insurance company to justify a standard-of-care test, it reduces the time available for direct patient care and increases provider burnout.
Industry pushback and the cost debate
While patient advocates and providers have long argued that prior authorizations increase overall costs by delaying preventative care, the insurance industry maintains a different view. Insurers argue that these approvals are a necessary check to prevent unnecessary procedures and control the spiraling cost of medical spending.
Lora Pellegrini, president of the Massachusetts Association of Health Plans, acknowledged that the industry has worked to streamline authorizations but cautioned that administrative tweaks are not a cure for high costs. In a statement, Pellegrini argued that “those efforts must be paired with meaningful action to address the underlying drivers of cost growth — including rising hospital prices, outpatient facility costs, and prescription drug spending.”
Gov. Healey suggested that the new regulations would help control costs by reducing administrative overhead and preventing expensive emergency room visits that occur when primary care is delayed. However, the administration has not yet released specific figures on the expected savings.
Disclaimer: This article is for informational purposes only and does not constitute medical or legal advice. Patients should consult with their healthcare provider or insurance representative to determine how these regulatory changes affect their specific coverage.
The next phase of implementation will involve state health officials monitoring insurer compliance with the 24-hour response window and the elimination of annual renewals for chronic care. Updates on enforcement and any subsequent adjustments to the list of exempt services are expected to be released via the Executive Office of Health and Human Services.
Do you think these changes will improve your access to care? Share your thoughts in the comments or share this story with others affected by insurance delays.
